Press-release for stocks for novartis ag

| -4.14% | O: -4.79% H: 0.0% C: -0.23%
NVSEF | $93.6375 6.88% 82K

| -5.17% | O: 2.2% H: 0.0% C: -2.57%
NVS | $94.36 1.93% 0.0% 2.3M

| -6.92% | O: -1.55% H: 0.23% C: -0.03%
ABBV | $166.41 1.06% 0.0% 5.5M

| -7.32% | O: 1.04% H: 0.0% C: 0.0%
contract market

Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M

| -6.34% | O: -0.09% H: 0.86% C: 0.6%
DGX | $128.44 2.01% 0.0% 1.6M

Health Services

| 2.5% | O: 0.38% H: 0.69% C: -1.01%
NVS | $94.36 1.93% 0.0% 2.3M

| -7.46% | O: 0.32% H: 0.22% C: -0.2%
BIO | $279.73 -0.46% 0.0% 290K

| -16.42% | O: -0.53% H: 1.08% C: -0.59%
ABT | News | $107.28 1.91% 0.18% 10M

| -9.48% | O: 1.6% H: 0.0% C: 0.0%
QDEL | News M | $39.09 2.17% 2.12% 1.1M

| -11.75% | O: 0.18% H: 1.13% C: -3.31%
report respiratory global rsv virus diagnostics growth market

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 3.4K

| 471.43% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | News | $20.2 -14.18% 510

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

| -1.05% | O: -1.64% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

| -4.17% | O: -0.34% H: 0.0% C: -1.2%
NVS | $94.36 1.93% 0.0% 2.3M

| -8.8% | O: -1.57% H: 0.26% C: -0.47%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -5.4% | O: -0.48% H: 0.16% C: 0.0%
BAX | $39.47 -0.45% 0.0% 2.8M

| 0.23% | O: -0.96% H: 5.91% C: 3.74%
ABT | News | $107.28 1.91% 0.18% 10M

| -6.29% | O: -1.41% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -1.8% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

| -9.11% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Over-The-Counter Drug Market to Grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB as Key Market Contributors - 17000+ Technavio Reports
Published: 2024-01-24 (Crawled : 05:00) - prnewswire.com
RBGPF | $51.61 6.46% 4.7K

Consumer Non-Durables

| -27.36% | O: -1.75% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

| -10.09% | O: -3.01% H: 0.69% C: -0.75%
AZNCF | News | $138.24 -4.19% 800

| 0.96% | O: -0.42% H: 0.0% C: -1.8%
RBGLY | $10.35 -2.05% 990K

| -26.96% | O: -0.35% H: 0.07% C: -0.14%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.41% | O: 0.22% H: 0.43% C: -0.39%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 1.2% | O: 0.48% H: 0.66% C: -1.11%
ABT | News | $107.28 1.91% 0.18% 10M

| -6.59% | O: -3.45% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -7.55% | O: 0.92% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 2.7% | O: -0.03% H: 0.29% C: -0.19%
drug astrazeneca key therapeutics market

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -8.68% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $138.24 -4.19% 800

| 3.34% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | $93.6375 6.88% 82K

| -12.49% | O: 1.4% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

| -1.32% | O: -0.18% H: 2.37% C: 2.28%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.82% | O: 0.12% H: 0.39% C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M

| 1.95% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.64% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 3.02% | O: 1.8% H: 0.14% C: -0.89%
AMGN | $269.03 2.39% 2.33% 3.4M

| -12.63% | O: 0.29% H: 1.12% C: 0.47%
research growth market

Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published: 2024-01-17 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 3.11% | O: -0.56% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

| -10.78% | O: -1.83% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

| -4.26% | O: -1.02% H: 0.95% C: -1.46%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.38% | O: 0.49% H: 0.18% C: 0.04%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -0.33% | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $107.28 1.91% 0.18% 10M

| -5.46% | O: 0.12% H: 0.77% C: 0.27%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -10.39% | O: 0.45% H: 0.06% C: -0.5%
ANIK | $25.84 1.61% 1.59% 49K

| 17.72% | O: -1.05% H: 3.55% C: 3.31%
america osteoarthritis therapeutics growth market

Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027, The growing prevalence of chronic diseases to boost market growth - Technavio
Published: 2023-12-12 (Crawled : 05:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800

| 8.79% | O: 5.03% H: 0.0% C: -3.82%
NVSEF | $93.6375 6.88% 82K

| -2.46% | O: 1.56% H: 0.51% C: 0.51%
TMO | News | $544.78 0.6% 0.0% 1.7M

| 10.88% | O: 0.86% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

| -3.0% | O: 0.45% H: 0.75% C: 0.46%
ABBV | $166.41 1.06% 0.0% 5.5M

| 10.32% | O: 0.59% H: 1.23% C: 1.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -1.92% | O: 0.43% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 7.95% | O: 1.54% H: 0.06% C: -0.78%
AMGN | $269.03 2.39% 2.33% 3.4M

| -1.18% | O: 1.83% H: 0.04% C: -1.13%
growing growth market

Novartis delivers 12% sales and 21% core operating income growth from continuing operations (in cc¹). Executes Sandoz spin-off, achieves important innovation milestones, and raises FY 2023 guidance
Published: 2023-10-24 (Crawled : 05:00) - globenewswire.com
NVS | $94.36 1.93% 0.0% 2.3M

| -0.35% | O: -0.17% H: 1.02% C: 0.4%
sales innovation novartis growth

Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K

| -25.43% | O: -0.27% H: 1.38% C: 0.83%
VTRS A | $11.25 1.17% 1.16% 4.7M

| 18.8% | O: -0.95% H: 1.81% C: 0.53%
NVS | $94.36 1.93% 0.0% 2.3M

| -2.56% | O: 0.2% H: 0.44% C: -0.56%
ABBV | $166.41 1.06% 0.0% 5.5M

| 12.5% | O: -0.32% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -15.25% | O: -0.4% H: 0.0% C: 0.0%
PHGE | $0.2852 -3.58% 3.16% 69K

| -3.33% | O: 5.0% H: 3.17% C: -1.56%
america dermatitis market

Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio
Published: 2023-10-11 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 8.05% | O: -1.75% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

| 1.35% | O: 0.07% H: 0.0% C: -0.38%
NVSEF | $93.6375 6.88% 82K

| -4.77% | O: 0.03% H: 0.0% C: -0.23%
ALPMY | $9.47 -1.11% 520K

| -30.98% | O: -3.81% H: 5.97% C: 2.57%
VTRS A | $11.25 1.17% 1.16% 4.7M

| 16.94% | O: 0.0% H: 1.3% C: 0.73%
NVS | $94.36 1.93% 0.0% 2.3M

| -4.17% | O: 1.03% H: 0.03% C: -0.07%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 6.45% | O: 0.72% H: 0.24% C: -0.13%
ABBV | $166.41 1.06% 0.0% 5.5M

| 11.39% | O: -0.08% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -14.65% | O: 1.1% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 0.79% | O: -0.31% H: 0.34% C: 0.31%
asia growth market

Novartis executes Sandoz Spin-off, completing strategic transformation into a leading, focused innovative medicines company
Published: 2023-10-04 (Crawled : 05:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

| 13.75% | O: 17.72% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

| -5.13% | O: -3.27% H: 0.0% C: 0.0%
company novartis

Onychomycosis Treatment Market size to grow by USD 1,776.53 million from 2022 to 2027; Growth driven by increasing prevalence of onychomycosis - Technavio
Published: 2023-08-15 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -12.75% | O: -2.02% H: 0.0% C: -1.05%
ALPMY | $9.47 -1.11% 520K

| -38.23% | O: 0.78% H: 0.39% C: -2.39%
NVS | $94.36 1.93% 0.0% 2.3M

| -8.72% | O: -0.32% H: 0.18% C: -0.44%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 12.16% | O: -0.51% H: 0.24% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -12.69% | O: 0.36% H: 0.0% C: 0.0%
treatment growth market

Oncology Drugs Market to grow at a CAGR of 11.99% from 2022 to 2027. AbbVie Inc., Amgen Inc. & Apikos Pharma are major vendors - Technavio
Published: 2023-07-27 (Crawled : 05:00) - prnewswire.com
ABBNY | News | $48.37 4.05% 180K

| 22.34% | O: 2.13% H: 0.04% C: -1.67%
ABLZF | News | $48.065 -32.74% 4.7K

Producer Manufacturing

| 22.06% | O: 0.58% H: 0.0% C: -0.46%
GLAXF | News | $20.2 -14.18% 510

| 12.04% | O: 2.38% H: 2.49% C: 2.49%
ALPMY | $9.47 -1.11% 520K

| -36.33% | O: 3.75% H: 0.0% C: -2.78%
NVS | $94.36 1.93% 0.0% 2.3M

| -9.17% | O: 0.7% H: 0.12% C: -0.76%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 10.82% | O: 1.03% H: 0.39% C: -1.02%
ABBV | $166.41 1.06% 0.0% 5.5M

| 17.64% | O: 2.13% H: 4.77% C: 3.02%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -12.74% | O: 0.92% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

| 14.34% | O: -0.31% H: 1.71% C: 0.67%
pharma abbvie market

Novartis delivers strong sales growth, robust margin expansion and raises guidance. Announces USD 15 billion share buyback and Board endorses Sandoz spin-off[1],[2]
Published: 2023-07-18 (Crawled : 05:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K

| 15.38% | O: 1.65% H: 5.27% C: 5.27%
NVS | $94.36 1.93% 0.0% 2.3M

| -4.63% | O: 2.92% H: 2.33% C: 1.6%
sales expansion novartis

Heparin Market size is set to grow by USD 3,009.44 million from 2022 to 2027|Growing prevalence of chronic conditions boosts the market- Technavio
Published: 2023-07-12 (Crawled : 05:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M

| 9.76% | O: 0.98% H: 0.97% C: -1.06%
NVS | $94.36 1.93% 0.0% 2.3M

| -2.88% | O: 0.29% H: 0.49% C: 0.26%
BAX | $39.47 -0.45% 0.0% 2.8M

| -14.25% | O: 0.96% H: 0.52% C: -0.19%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -10.77% | O: -0.89% H: 0.0% C: 0.0%
set market

CRISPR technology market size to grow by USD 2.88 billion from 2021 to 2026; Addgene Inc. and Agilent Technologies Inc., among others, identified as key vendors - Technavio
Published: 2023-04-13 (Crawled : 05:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
CRBU | $3.87 -1.02% -1.03% 1.7M

| -11.09% | O: 0.23% H: 12.9% C: 11.75%
TMO | News | $544.78 0.6% 0.0% 1.7M

| -5.97% | O: 1.02% H: 1.17% C: 1.0%
NVS | $94.36 1.93% 0.0% 2.3M

| -2.19% | O: 1.3% H: 0.56% C: 0.51%
CRSP M | $55.04 -1.99% -2.03% 1.8M

| 26.64% | O: 1.77% H: 14.78% C: 14.29%
crispr technology market

Hedgehog pathway inhibitors market size to grow by USD 385.52 million from 2021 to 2026; Bristol Myers Squibb Co., Infinity Pharmaceuticals Inc., among others, identified as key vendors - Technavio
Published: 2023-04-12 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

| -15.5% | O: 3.22% H: 0.01% C: 0.01%
NVSEF | $93.6375 6.88% 82K

| 17.97% | O: 1.1% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

| -1.5% | O: 0.75% H: 0.5% C: -0.05%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -16.82% | O: 0.47% H: 0.0% C: 0.0%
pharmaceuticals market

Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio
Published: 2023-02-20 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

| Email alert Add to watchlist
GLAXF | News | $20.2 -14.18% 510

| Email alert Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

| Email alert Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M

| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M

| Email alert Add to watchlist
RLFTY | $1.4006 733.33% 100

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

| Email alert Add to watchlist
RLFTF | $1.43 11.45% 3.8K

| Email alert Add to watchlist
america care cancer growth market

Biologic Therapy Market to record USD 226.61 Bn growth -- North America to account for 57% market share
Published: 2022-09-19 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 31.25% | O: -8.32% H: 12.85% C: 9.85%
SNYNF | News | $92.7 -2.18% 600K

| 16.59% | O: -1.9% H: 0.21% C: 0.21%
AZNCF | News | $138.24 -4.19% 800

| 20.53% | O: 1.63% H: 0.14% C: -3.38%
NVS | $94.36 1.93% 0.0% 2.3M

| 17.0% | O: -0.52% H: 0.69% C: 0.62%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 28.93% | O: -0.55% H: 0.64% C: 0.39%
ABBV | $166.41 1.06% 0.0% 5.5M

| 15.51% | O: -0.29% H: 0.15% C: -0.68%
SNY | News | $46.32 2.05% 2.01% 3.3M

| 14.43% | O: -0.33% H: 0.0% C: 0.0%
IDYA | $37.1 -1.38% -1.4% 730K

| 232.71% | O: -0.27% H: 8.45% C: 7.1%
AZN | News | $68.56 0.29% 0.29% 4.7M

| 18.09% | O: -0.14% H: 0.09% C: 0.03%
america therapy growth market

Botanical and Plant-Derived Drugs Market to Grow by USD 15.89 bn | Technavio
Published: 2022-03-01 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| -5.61% | O: 0.75% H: 0.0% C: -7.0%
SNYNF | News | $92.7 -2.18% 600K

| -15.3% | O: -3.33% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| 9.49% | O: 2.9% H: 0.0% C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M

| 8.45% | O: 1.3% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -5.24% | O: -0.05% H: 0.81% C: -0.91%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -11.12% | O: -1.3% H: 0.0% C: 0.0%
JAZZ | $109.96 0.63% 0.63% 760K

| -20.04% | O: -1.14% H: 1.11% C: 0.51%
drug

← Previous
1
2
Next →

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

Finance

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K